Medtronic (MDT): FY25 Q2 earnings call, Nov 19, 2024
No Kalshi or Polymarket word markets were listed for Medtronic’s Nov 19, 2024 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
11 matches for “PulseSelect”; 5 quoted, at least 25 words apart.
…and focal PFA catheters. We continue to drive our growth of our PulseSelect PFA single-shot catheter. This is offsetting cryoablation declines and our rate of…
…supplier interruption. They've now expanded capacity, allowing us to continue to ramp PulseSelect availability and activate new accounts. On top of PulseSelect, we were pleased…
…but early in their life cycle on margin expansion, renal denervation, both PulseSelect, which had the supplier issue this quarter, and the upcoming or ongoing…
…expanded capacity as well, and which is allowing us to ramp the PulseSelect supply and activate new accounts, PulseSelect is doing well. I mean --…
…mentioned, we did double -- or close to double the physicians using PulseSelect, and we'll now have confidence to open more accounts, so that should…
Agents: this page as TSV at /api/v1/appearances/medtronic:2024-11-19:earnings_call · words: /api/v1/brief?appearance=medtronic:2024-11-19:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP